1. Stocks
    2. /
  2. Telix Pharmaceuticals (ASX: TLX)
    3. /

Telix Pharmaceuticals (ASX: TLX) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Telix Pharmaceuticals Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Telix Pharmaceuticals (ASX: TLX)
    Latest News

    Doctor doing a telemedicine using laptop at a medical clinic
    Healthcare Shares

    Up 80% in 2024, here's why the Telix Pharmaceuticals share price is marching higher again on Monday

    | Bernd Struben

    ASX investors have been piling into Telix Pharmaceuticals shares. But why?

    Read more »

    A man wearing glasses and a white t-shirt pumps his fists in the air looking excited and happy about the rising OBX share price
    Share Gainers

    These were the best performing ASX 200 shares in May 2024

    | James Mickleboro

    These shares made their shareholders smile in May.

    Read more »

    A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
    Share Gainers

    Why AVITA Medical, Catapult, Meridian Energy, and Telix shares are storming higher today

    | James Mickleboro

    These ASX shares are ending the week strongly. But why?

    Read more »

    A medical researcher works on a bichip, indicating share price movement in ASX tech companies
    Healthcare Shares

    Why is the Telix Pharmaceuticals share price soaring 11% today?

    | Bernd Struben

    The Telix Pharmaceuticals share price is rocketing on Friday. But why?

    Read more »

    Shot of a young scientist using a digital tablet while working in a lab.
    Healthcare Shares

    Which ASX biotech shares are pioneering the future of medicine?

    | Kate O'Brien

    Uncover the risks and rewards of high-stakes investments in ASX biotech stocks.

    Read more »

    A young woman makes an online travel booking as she sits on some steps with her suitcase next to her.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    ASX shares snatched defeat from the jaws of victory today.

    Read more »

    Two smiling work colleagues discuss an investment at their office.
    Share Gainers

    Why Droneshield, TechnologyOne, Telix, and Webjet shares are rising today

    | James Mickleboro

    These shares are having a great session. But why?

    Read more »

    A piggy bank on the cloud in the blue sky symbolising a record high share price.
    52-Week Highs

    Guess which 7 ASX 200 shares are smashing new 52-week highs today

    | Bernd Struben

    Investors are sending these seven stocks soaring to new one-year highs today.

    Read more »

    Woman with speaker
    Investing Strategies

    Inherited a substantial sum of money? Here's how I'd spend it (including the ASX stocks I'd buy)

    | Rhys Brock

    Inheriting a substantial sum of money can be life changing – but working out the best way to use it…

    Read more »

    A businesswoman on the phone is shocked as she looks at her watch, she's running out of time.
    Growth Shares

    Two high-flying ASX shares: One upgraded, one downgraded

    | James Mickleboro

    One of these high-flying shares could keep rising and one could fall.

    Read more »

    Ten smiling business people wave to the camera after receiving some winning company news.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    Let's also take a look at what the various ASX sectors were doing this Wednesday.

    Read more »

    Happy healthcare workers in a labs
    Healthcare Shares

    Up 74% in 6 months, guess which ASX 200 healthcare stock just hit another all-time high

    | Mitchell Lawler

    This company has busily deployed cash over the past six months while growing at a phenomenal pace.

    Read more »

    Frequently Asked Questions

    No, Telix does not pay dividends at this time. 

    Telix Pharmaceuticals Ltd listed on the ASX on 15 November 2017.

    TLX ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Telix Pharmaceuticals

    Telix Pharmaceuticals Ltd (ASX: TLX) is a commercial-stage biopharmaceutical company focused on the ongoing development of diagnostic and therapeutic ('theranostic') products using targeted radiation. This process treats cancerous or diseased cells, an alternative approach to many cancer therapies which also attack healthy tissue at the same time.

    Telix has received global regulatory approvals from the Australian Therapeutic Goods Administration (TGA), the US Food and Drug Administration (FDA), and Health Canada for its prostate cancer imaging agent Illuccix. It is working to get Illuccix approved for sale in the UK and Europe. 

    The company also has more than 20 clinical trials underway worldwide. Telix's research and development is focused on prostate, renal (kidney), glioblastoma (brain), and hematologic (bone marrow conditioning) cancers, as well as rare diseases. The company is headquartered in Australia with offices in Belgium, Japan, Switzerland, and the United States. 

    Profile

    since

    Note